John W. Calvert

13.3k total citations · 2 hit papers
107 papers, 9.8k citations indexed

About

John W. Calvert is a scholar working on Molecular Biology, Physiology and Biochemistry. According to data from OpenAlex, John W. Calvert has authored 107 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 40 papers in Physiology and 33 papers in Biochemistry. Recurrent topics in John W. Calvert's work include Nitric Oxide and Endothelin Effects (29 papers), Sulfur Compounds in Biology (28 papers) and Cardiac Ischemia and Reperfusion (22 papers). John W. Calvert is often cited by papers focused on Nitric Oxide and Endothelin Effects (29 papers), Sulfur Compounds in Biology (28 papers) and Cardiac Ischemia and Reperfusion (22 papers). John W. Calvert collaborates with scholars based in United States, Japan and Australia. John W. Calvert's co-authors include David J. Lefer, John H. Zhang, Susheel Gundewar, John W. Elrod, Saurabh Kumar Jha, Chad K. Nicholson, Arun Ramachandran, Christopher G. Kevil, Nathan S. Bryan and Mark R Duranski and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

John W. Calvert

106 papers receiving 9.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function

2007 1.0k citations John W. Elrod, John W. Calvert et al. Proceedings of the National Academy of Sciences profile →
Hydrogen Sulfide Mediates Cardioprotection Through Nrf2 Signaling

2009 637 citations John W. Calvert, Saurabh Kumar Jha et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John W. Calvert United States	51	3.5k	3.4k	2.6k	1.5k	1.4k	107	9.8k
Jin‐Song Bian China	61	5.4k 1.5×	4.0k 1.2×	2.2k 0.8×	1.1k 0.7×	991 0.7×	231	11.5k
John W. Elrod United States	41	2.1k 0.6×	3.9k 1.2×	1.8k 0.7×	1.3k 0.8×	915 0.7×	109	8.1k
Fumito Ichinose United States	51	1.5k 0.4×	1.9k 0.6×	2.0k 0.8×	1.5k 1.0×	648 0.5×	183	7.4k
Sruti Shiva United States	64	1.6k 0.5×	6.0k 1.8×	5.5k 2.1×	1.7k 1.1×	1.6k 1.1×	224	15.7k
Neal L. Weintraub United States	60	2.3k 0.7×	3.7k 1.1×	2.5k 1.0×	3.0k 2.0×	1.0k 0.7×	268	11.9k
Junbao Du China	54	5.8k 1.6×	2.3k 0.7×	2.4k 0.9×	1.8k 1.2×	763 0.6×	304	10.1k
Zvonimir S. Katušić United States	62	1.7k 0.5×	3.7k 1.1×	5.6k 2.1×	2.9k 1.9×	704 0.5×	230	11.9k
William Durante United States	49	1.3k 0.4×	3.9k 1.2×	1.8k 0.7×	1.2k 0.8×	803 0.6×	133	7.7k
Santiago Lamas Spain	59	1.9k 0.5×	6.5k 1.9×	4.7k 1.8×	1.8k 1.2×	841 0.6×	164	14.4k
Chaoshu Tang China	49	4.1k 1.2×	2.1k 0.6×	2.0k 0.8×	1.5k 0.9×	668 0.5×	258	8.1k

Countries citing papers authored by John W. Calvert

Since Specialization

Citations

This map shows the geographic impact of John W. Calvert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John W. Calvert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John W. Calvert more than expected).

Fields of papers citing papers by John W. Calvert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John W. Calvert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John W. Calvert. The network helps show where John W. Calvert may publish in the future.

Co-authorship network of co-authors of John W. Calvert

This figure shows the co-authorship network connecting the top 25 collaborators of John W. Calvert. A scholar is included among the top collaborators of John W. Calvert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John W. Calvert. John W. Calvert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shimizu, Yuuki, et al.. (2023). Cardiac Lymphatic Insufficiency Leads to Diastolic Dysfunction Via Myocardial Morphologic Change. JACC Basic to Translational Science. 8(8). 958–972. 8 indexed citations

Cho, Kyu-Won, Sangsung Kim, Jin Eyun Kim, et al.. (2023). Polycomb Group Protein CBX7 Represses Cardiomyocyte Proliferation Through Modulation of the TARDBP/RBM38 Axis. Circulation. 147(24). 1823–1842. 13 indexed citations

Qin, Dongze, Anis Hanna, Jaehoon Lee, et al.. (2023). BAK contributes critically to necrosis and infarct generation during reperfused myocardial infarction. Journal of Molecular and Cellular Cardiology. 184. 1–12. 3 indexed citations

Suzuki, Junya, Yuuki Shimizu, Rei Shibata, et al.. (2022). Hydrogen Sulfide Attenuates Lymphedema Via the Induction of Lymphangiogenesis Through a PI3K/Akt‐Dependent Mechanism. Journal of the American Heart Association. 11(21). e026889–e026889. 12 indexed citations

D’Agostino, Emma H., Xiangsheng Huang, Guohui Wang, et al.. (2022). A phospholipid mimetic targeting LRH-1 ameliorates colitis. Cell chemical biology. 29(7). 1174–1186.e7. 9 indexed citations

Tan, Lin, John W. Calvert, Robert M. Graham, et al.. (2022). Remuscularization with triiodothyronine and β1-blocker therapy reverses post-ischemic left ventricular dysfunction and adverse remodeling. Scientific Reports. 12(1). 8852–8852. 3 indexed citations

Tan, Lin, Jennifer Perry, John W. Calvert, et al.. (2019). Redox activation of JNK2α2 mediates thyroid hormone-stimulated proliferation of neonatal murine cardiomyocytes. Scientific Reports. 9(1). 17731–17731. 17 indexed citations

Iismaa, Siiri E., Ming Li, Scott Kesteven, et al.. (2018). Cardiac hypertrophy limits infarct expansion after myocardial infarction in mice. Scientific Reports. 8(1). 6114–6114. 13 indexed citations

Tejada, Thor, Lin Tan, John W. Calvert, et al.. (2016). IGF-1 degradation by mouse mast cell protease 4 promotes cell death and adverse cardiac remodeling days after a myocardial infarction. Proceedings of the National Academy of Sciences. 113(25). 6949–6954. 35 indexed citations

10.

Naqvi, Nawazish, Ming Li, John W. Calvert, et al.. (2014). A Proliferative Burst during Preadolescence Establishes the Final Cardiomyocyte Number. Cell. 157(4). 795–807. 209 indexed citations

11.

Aragón, Juan Pablo, Marah E. Condit, Shashi Bhushan, et al.. (2011). Beta3-Adrenoreceptor Stimulation Ameliorates Myocardial Ischemia-Reperfusion Injury Via Endothelial Nitric Oxide Synthase and Neuronal Nitric Oxide Synthase Activation. Journal of the American College of Cardiology. 58(25). 2683–2691. 105 indexed citations

12.

Calvert, John W., Chad K. Nicholson, Susheel Gundewar, et al.. (2010). Genetic and Pharmacologic Hydrogen Sulfide Therapy Attenuates Ischemia-Induced Heart Failure in Mice. Circulation. 122(1). 11–19. 259 indexed citations

13.

Nicholson, Chad K. & John W. Calvert. (2010). Hydrogen sulfide and ischemia–reperfusion injury. Pharmacological Research. 62(4). 289–297. 147 indexed citations

14.

Calvert, John W., William A. Coetzee, & David J. Lefer. (2009). Novel Insights Into Hydrogen Sulfide–Mediated Cytoprotection. Antioxidants and Redox Signaling. 12(10). 1203–1217. 280 indexed citations

15.

Calvert, John W. & David J. Lefer. (2009). Clinical translation of nitrite therapy for cardiovascular diseases. Nitric Oxide. 22(2). 91–97. 58 indexed citations

16.

Elrod, John W., John W. Calvert, Susheel Gundewar, Nathan S. Bryan, & David J. Lefer. (2008). Nitric oxide promotes distant organ protection: Evidence for an endocrine role of nitric oxide. Proceedings of the National Academy of Sciences. 105(32). 11430–11435. 95 indexed citations

17.

Calvert, John W., Susheel Gundewar, Saurabh Kumar Jha, John W. Elrod, & David J. Lefer. (2008). Abstract 3547: Hydrogen Sulfide Therapy Attenuates Left Ventricular Dysfunction and Reduces Mortality in a Murine Model of Heart Failure. Circulation. 118. 1 indexed citations

18.

Shiva, Sruti, Michael N. Sack, James J.M. Greer, et al.. (2007). Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer. The Journal of Experimental Medicine. 204(9). 2089–2102. 453 indexed citations

19.

Elrod, John W., John W. Calvert, Mark R Duranski, & David J. Lefer. (2006). Abstract 947: Hydrogen Sulfide Donor Protects Against Acute Myocardial Ischemia-Reperfusion Injury. Circulation. 114(4). 409–416. 2 indexed citations

20.

Calvert, John W., Changman Zhou, & John H. Zhang. (2004). Transient exposure of rat pups to hyperoxia at normobaric and hyperbaric pressures does not cause retinopathy of prematurity. Experimental Neurology. 189(1). 150–161. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact